Rigel Pharmaceuticals (RIGL)

Add to Watchlists Create an Alert
4.71 +0.07  +1.51%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Rigel Pharmaceuticals News

Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye
PR Newswire May 22

SOUTH SAN FRANCISCO, Calif., May 22, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the clinical advancement of three programs in development. The first program is a wholly-owned ...

Narrower-Than-Expected Loss at Rigel Pharma - Analyst Blog
Zacks May 9

Rigel Pharma's first-quarter 2013 loss of 29 cents per share was narrower than the Zacks Consensus Estimate of a loss of 32 cents.

Rigel Announces First Quarter 2013 Financial Results
PR Newswire May 7

SOUTH SAN FRANCISCO, Calif., May 7, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the first quarter ended March 31, 2013. For the first quarter of ...

April's Unhealthiest Stocks
Fool May 4

These three health-care picks nosedived last month on earnings and disappointing drug data.

Rigel Pharmaceuticals Becomes Oversold (RIGL)
May 3

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

3 Biggest Biotech Crashes in April
Fool May 1

When biotechs fall, they fall hard. These three fell the hardest in April.

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
RIGL 4.71 +0.07 +1.51% 410.00M
New watchlist
Create
Success.

Your new watchlist has been created

View WatchlistsDone
Create Watchlist from Quotes

Register for your Free YCharts Account.

Understand your investments with more data than any other free site.

  • Create watchlists that you care about for stocks or economic indicators
  • Create alerts to track the movements of your stocks
  • Access stock analysis from our in-house experts
Get Started Now

Already registered? Sign in to your account.

document.write('');